Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Health Spending

Kaiser Daily Global Health Policy ReportEnvironment and Climate Change Search Results « » The Henry J. Kaiser Family Foundation

Environment and Climate Change

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Also In Global Health News: Tentative ARV Approval Under PEPFAR; 50 Years Of Peace Corps; Clean Water In Zimbabwe; Development In Southern Sudan

Matrix Laboratories Recieves Tentative FDA Approval To Provide Generic ARV Under PEPFAR Pharmaceutical company Mylan announced on Tuesday that its “subsidiary Matrix Laboratories Ltd. has received tentative government approval for atazanavir sulfate capsules, an AIDS treatment that will be available in some developing countries,” Pittsburgh Business Times reports. “Atazanavir sulfate capsules…

Recent Releases In Global Health

Lancet Infectious Diseases Examines Funding In Relation To Disease Burden: In response to two recent papers on neglected tropical diseases, Nicola Dmitri of the University of Siena in a Lancet Infectious Diseases Reflection addresses “how research funds could be guided by [the global burden of disease] GBD.” The results show, for example,…

Also In Global Health News: African Bank Donates To Global Fund; Dengue-Blocking Mosquitoes; Maternal Health In Afghanistan; Leishmaniasis Drug; HIV/AIDS In Ukraine; Malnutrition In Mozambique; MDR-TB Study

Africa’s Access Bank Donates $1M To Global Fund Africa’s Access Bank “has announced a donation of the sum of $1 million to the Global Fund’s Gift from Africa” project redeemable over a 3-year period (2010 – 2012),” according to the New Times/allAfrica.com. Aigboje Aig-Imoukhuede, Access Bank’s group managing director, said…

Also In Global Health News: Generic Drugs From India; Rapid TB Test; U.S.-India Agriculture Dialogue; Zimbabwe’s Health Sector; ‘Superbug’ In U.S.

Changing Trade Rules In India Could Impede Access To Generic Drugs Generic drugs produced in India “could cost more and be harder to access if the country has to adhere to stricter intellectual property rules,” Reuters reports, noting that the country supplies the “bulk” of AIDS medicines that go developing…